Delivery Order SPE2DB22D2206-SPE2DB25FJD60
- Not listed
- The Defense Logistics Agency (DLA) awarded a $26,329.73 firm fixed price delivery order to AmerisourceBergen Drug Corp for Orencia ClickJect 125 mg/ml on July 23, 2025, with an ultimate completion date of July 24, 2025. This competitive award carries no set-aside designation and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC)...
- The U.S. Defense Logistics Agency (DLA) awarded a $6,998.08 firm fixed-price delivery order contract to AmerisourceBergen Drug Corporation's Corporate Office division for the supply of Orencia ClickJect 125 mg/ml pharmaceutical products. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical for providing a comprehensive range of medical commodities to support military treatment programs...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $28,232.34 contract is for the provision of Orencia 125 mg/ml syringes, with a completion date of February 9, 2024. AmerisourceBergen Drug Corp serves as the prime contractor on this delivery order, which is not designated as a set-aside...
- The Defense Logistics Agency (DLA) awarded a $17,548.12 delivery order to AmerisourceBergen Drug Corp for Orencia Clickject 125 mg/ml, a biologic medication used to treat rheumatoid arthritis and other inflammatory conditions. The contract, awarded on July 21, 2025, with an ultimate completion date of July 22, 2025, is structured as a firm fixed-price delivery order with no set-aside designation. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $19,402.97 firm-fixed-price delivery order is for the supply of Orencia 250 mg vials, with a completion date of November 27, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Orencia 125 mg/ml syringes with a ceiling value of $8,140.49. This firm fixed-price delivery order represents a non-set-aside competitive award and is expected to be completed by July 23, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, reflecting the company's role as a major pharmaceutical distributor...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,879 firm fixed-price delivery order is for the supply of 250 mg vials of the medication Orencia. The contract has an ultimate completion date of November 27, 2024 and was awarded on November 26, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- The Defense Logistics Agency awarded a delivery order valued at $10,782.12 to AmerisourceBergen Drug Corp for Orencia ClickJect 125 mg/mL, a pharmaceutical product used in rheumatoid arthritis treatment. This competitively awarded, firm fixed-price delivery order was issued on July 28, 2025, with an ultimate completion date of July 29, 2025. The contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- This federal contract award from the Defense Logistics Agency (DLA) was made to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,282.52 firm fixed-price delivery order is for the supply of Orencia 125 mg/ml syringes, a medication used to treat various autoimmune conditions. The contract has an ultimate completion date of May 14, 2025 and is not set aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite...
- This is a $9,234.61 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the supply of Orencia 250 mg vials, a specialty pharmaceutical product. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for a comprehensive range of medical commodities to...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FJD60Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Orencia 250 mg vials, with a contract ceiling value of $14,863.40. The award, issued on July 30, 2025, is a firm fixed-price delivery order with an ultimate completion date of July 31, 2025. This non-competitive set-aside award represents a specific pharmaceutical procurement from AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen's larger $999.999 billion IDC vehicle with DLA Troop Support Medical (designated SPE2DX), which runs through December 2026 and provides comprehensive global pharmaceutical support for military healthcare programs. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen supplies a broad portfolio of brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. Orencia (abatacept) is a biologic immunosuppressant used primarily for rheumatoid arthritis and other autoimmune conditions, representing the type of specialized pharmaceutical product maintained within the company's extensive federal supply network.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.9k | 7/30/25 |